title: Is there a role for omacetaxine in the management of chronic myelogenous leukemia in the era of the tyrosine kinase inhibitors?
authors.affiliation: Division of Hematology, McGill University , Montreal, Quebec , Canada.
authors.forename: Moussab
authors.initials: M
authors.lastname: Damlaj
authors.forename: Sarit
authors.initials: S
authors.lastname: Assouline
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D005260:Female; D006248:Harringtonines / Q000627:therapeutic use*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology*; D008297:Male
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D006248:Harringtonines